The status of targeted agents in the setting of neoadjuvant radiation therapy in locally advanced rectal cancers.
about
STED super-resolution microscopy of clinical paraffin-embedded human rectal cancer tissue.Critical role of bevacizumab scheduling in combination with pre-surgical chemo-radiotherapy in MRI-defined high-risk locally advanced rectal cancer: Results of the BRANCH trialThe changes of tumour vascular endothelial growth factor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma.Targeted therapies in colorectal cancer: the dos, don'ts, and future directionsTargeting progastrin enhances radiosensitization of colorectal cancer cells.New perspectives in treatment decision for integrated management of rectal cancer: multimodal research for multimodal treatments.
P2860
The status of targeted agents in the setting of neoadjuvant radiation therapy in locally advanced rectal cancers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The status of targeted agents ...... cally advanced rectal cancers.
@en
The status of targeted agents ...... cally advanced rectal cancers.
@nl
type
label
The status of targeted agents ...... cally advanced rectal cancers.
@en
The status of targeted agents ...... cally advanced rectal cancers.
@nl
prefLabel
The status of targeted agents ...... cally advanced rectal cancers.
@en
The status of targeted agents ...... cally advanced rectal cancers.
@nl
P2093
P2860
P1476
The status of targeted agents ...... cally advanced rectal cancers.
@en
P2093
Maher Hadaki
Mark Harrison
Rob Glynne-Jones
P2860
P304
P356
10.3978/J.ISSN.2078-6891.2013.037
P577
2013-09-01T00:00:00Z